- Home
- Companies
- Evofem Biosciences, Inc.
- Products
- Evofem - Model EVO200 - Recurrent ...
Evofem - Model EVO200 - Recurrent Bacterial Vaginosis (BV)
EVO200 is an investigational vaginal pH modulator in development for the prevention of recurrent Bacterial Vaginosis (BV). In a Phase 1 dose-finding trial for this indication, the highest dose formulation of the study drug demonstrated reduced vaginal pH for up to seven days following a single administration. EVO200 has been designated a QIDP by the FDA for this indication.
-
Most popular related searches
Customer reviews
No reviews were found for Evofem - Model EVO200 - Recurrent Bacterial Vaginosis (BV). Be the first to review!